Schering-Plough Merck Reverse Merger Shareholder Class Action

Schering-Plough and Merck announced plans for a reverse merger to form one company. Under the terms of the reverse merger, Schering-Plough shareholders would be given $10.56 in cash and .5767 shares of Merck stock for each Schering-Plough share. Although these provisions appeared to provide a premium to Schering-Plough stock owners when the deal was announced, many believe that the deal has been grossly unfair to Schering-Plough stockholders. Merck will gain control of the merged companies from the reverse-merger causing Schering-Plough stockholders to object to the proposed reverse merger.

Contact Us

If you own Schering-Plough stock and you object to the Schering-Plough Merck reverse merger, and you would like to speak with an attorney about your rights, contact Seeger Weiss LLP. Our securities fraud team is investigating the Merck Schering-Plough reverse merger for a potential shareholder class action on behalf of Schering-Plough shareholders who feel they have not been offered a reasonable value for their investment. Please use the contact form or call 888-584-0411. Attorney consultations incur no obligation on your part. All initial consultations are free of charge and do not create an attorney-client relationship. Seeger Weiss LLP has office locations in New York, New Jersey, Pennsylvania and California and its attorneys are available to practice in courts throughout the country.

• Seeger Weiss Wins 5th Verdict Against Accutane Maker, Dealing a $25.16 Million Blow
• Seeger Weiss Delivers $11 Million Verdict to Small, Family Farms Overrun by Corporate Agriculture's Waste
• Seeger Weiss Obtains $41.5 Million Global Resolution of Zetia and Vytorin Claims
• Seeger Weiss Secures $4.85 Billion Vioxx Settlement from Merck
• Seeger Weiss Named to National Law Journal's Plaintiffs' Hot List Three Years Running
• Seeger Weiss & Milberg Drive Bernie Madoff into Personal Bankruptcy